Laddar...
Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells
BACKGROUND: Thalidomide is an immunomodulatory agent, which arrests angiogenesis. The mechanism of anti-angiogenic activity of thalidomide is not fully understood. As nitric oxide is involved in angiogenesis, we speculate a cross-talk between thalidomide and nitric oxide signaling pathway to define...
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2006
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1456963/ https://ncbi.nlm.nih.gov/pubmed/16584574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2121-7-17 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|